Early Non-Ablative Fractional Laser Resurfacing for Acne Scars After Treatment With Oral Isotretinoin
Status:
Completed
Trial end date:
2017-06-14
Target enrollment:
Participant gender:
Summary
Patients who have completed have completed a cumulative dose of >=120miligram/kilogram oral
isotretinoin within the last 30 days, and has mild to moderate acne scarring will be
randomized, into a right-left comparison study using Fraxel DUAL (Solta Medical) laser on one
side of the face, and no treatment on the other side of the face. Subejcts will receive
treatments at week 0, week 4, and week 8. Photographs will be taken after each treatment, 7
days after each treatment, and 4 months after last treatment. Photographs will be reviewed by
blind assessors who will analyze the pre- and post-treatment photographs to measure change.